My research projects are focused in developing tools that facilitate the study of cellular signals in the tumor microenvironment relevant to disease progresion and therapy. We combine nanoparticle aproaches for drug delivery and microfluidic technology for in vitro modeling of tumor-mesencymal interactions in breast cancer. Our main goal is to develop gene signatures that can identify patients for cell - targeted therapies and uncover new cellular signals as potential clinical candidates for therapy.